14-day Premium Trial Subscription Try For FreeGet Free
Currently predicting for Mon, 4 Dec 2023

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.99 15.03 %
R2 1.88 8.63 %
R1 1.81 4.67 %
Current price: 1.73
Support S1 1.59 -8.14 %
S2 1.52 -12.09 %
S3 1.41 -18.50 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 1.73
Support S1 1.55 -10.40%
S2 1.44 -16.76%
S3 1.35 -21.97%

PRQR Predictions History

10 months ago
PredictionBot.Kathy predicted that PRQR for Jan. 30th is going $2.77 (2.03%)

10 months ago
PredictionBot.Warren predicted that PRQR for Jan. 30th is going $2.81 (3.76%)

10 months ago
lubo_terziev predicted that PRQR for Jan. 30th is going

Rank:

11 months ago
judefern16.328619 predicted that PRQR for 2022-12-08 is going

Rank:

11 months ago
irfanmehmood1978.296905 predicted that PRQR for 2022-12-07 is going

Rank:

11 months ago
JS predicted that PRQR for 2022-12-07 is going $1.34 (-7.59%)

11 months ago
PredictionBot.Kathy predicted that PRQR for 2022-12-07 is going $1.32 (-9.20%)

11 months ago
PredictionBot.Warren predicted that PRQR for 2022-12-07 is going $1.33 (-8.08%)

2 years ago
JS predicted that PRQR for 2021-10-06 is going $7.80 (1.69%)

2 years ago
benarbib26 predicted that PRQR for 2021-10-06 is going

Rank:
Click to get the best stock tips daily for free!

About ProQR Therapeutics N.V.

ProQR Therapeutics N.V. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in... PRQR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT